Allecra   Report issue

For profit Phase 1 Phase 3
Founded: Weil Am Rhein Germany (2013)

Organization Overview

First Clinical Trial
2013
NCT03685084
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Allecra